Tumor surveillance via the ARF-p53 pathway

Genes and Development

Volumn 12, Issue 19, 1998, Pages 2984-2991

  Sherr, Charles J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

CANCER EPIDEMIOLOGY; CELL CYCLE G1 PHASE; CELL DIVISION; CELL PROLIFERATION; GENE DISRUPTION; GENE LOCUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS REGULATION; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0032191393     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.19.2984     Document Type: Review

References (82)

1. Askew, D.S., R.A. Ashmun, B.C. Simmons, and J.L. Cleveland. 1991. Constitutive c-myc expression in an IL3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922.
2. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. Mdm2 expression is induced by wild type p53 activity. EMBO J. 12: 461-468.
3. ARF links pRB and p53. Nature (in press).
4. Blasco, M.A., H.-W. Lee, M.P. Hande, E. Samper, P.M. Lansdorp, R.A. DePinho, and C.W. Greider. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34.
5. Bodnar, A.G., M. Ouellette, M. Frolkis, S.E. Holt, C.-P. Chiu, C.B. Morin, C.B. Harley, J.B. Shay, S. Lichsteiner, and W.E. Wright. 1998. Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
6. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird, M.L. Hooper, and A.H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
7. ARF tumor suppressor. Genes & Dev. 12: 2435-2443.
8. Demers, G.W., S.A. Foster, C.L. Halbert, and D.A. Galloway. 1994. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. 91: 4382-4386.
9. INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 11: 21-29.
10. Dyson, N. 1998. The regulation of E2F by pRb-family members. Genes & Dev. 12: 2245-2262.
11. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
12. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Water, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
13. Franza, B.R., K. Maruyama, J.I. Garrels, and H.E. Ruley. 1986. In vitro establishment is not sufficient prerequisite for transformation by activated ras oncogene. Cell 44: 409-418.
14. Fukusawa, K., T. Choi, R. Kuriyama, S. Rulong, and G.F. Vande Woude. 1996. Abnormal centrosome amplification in the absence of p53. Science 271: 1744-1747.
15. Giaccia, A.J. and M.B. Kastan. 1998. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes & Dev. 12: (this issue).
16. Gruis, N.A., P.A. van der Velden, L.A. Sandkuijl, D.E. Prins, J. Weaver-Feldhaus, A. Kamb, W. Bergman, and R. Frants. 1995. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat. Genet. 10: 351-353.
17. Gualberto, A., K. Aldape, K. Kozakiewicz, and T.D. Tlsty. 1998. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc. Natl. Acad. Sci. 95: 5166-5171.
18. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
19. Harvey, D.M. and A.J. Levine. 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes &. Dev. 5: 2375-2385.
20. Harvey, M., A.T. Sands, R.S. Weiss, M.E. Hegi, R.W. Wiseman, P. Pantazis, B.C. Giovanella, M.A. Tainsky, A. Bradley, and L.A. Donehower. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8: 2457-2467.
21. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
22. Hermeking, H. and D. Eick. 1994. Mediation of c-Myc-induced apoptosis by p53. Science 265: 2091-2093.
23. Hermeking, H., C. Lengauer, K. Polyak, T.-C. He, L. Zhang, S. Thiagalingam, K.W. Kinzler, and B. Vogelstein. 1997. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1: 3-11.
24. Hicks, G.C., S.E. Egan, A.H. Greenberg, and M. Mowat. 1991. Mutant p53 tumor suppressor alleles release ras-induced cell cycle growth arrest. Mol. Cell. Biol. 11: 1344-1352.
25. Hirakawa, T. and H.E. Ruley. 1991. Rescue of cells from ras oncogene-induced growth arrest by a second complementing oncogene. Proc. Natl. Acad. Sci. 85: 1519-1523.
26. Hollstein, M., K. Rice, M.S. Greenblatt, T. Soussi, R. Fuchs, T. Sorlie, E. Hovig, B. Smith-Sorensen, R. Montesano, and C.C. Harris. 1994. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 22: 3551-3555.
27. Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420: 25-27.
28. Howes, K.A., N. Ransom, D.S. Papermaster, J.G.H. Lasudry, D.M. Albert, and J.J. Windle. 1994. Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes & Dev. 8: 1300-1310.
29. Jacks, T. and R.A. Weinberg. 1996. Cell-cycle control and its watchman. Nature 381: 643-644.
30. Kamb, A., N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S.V. Tavtigian, E. Stocken, R.S. Day, III, B.E. Johnson, and M.H. Skolnick. 1994a. A cell cycle regulator involved in genesis of many tumor types. Science 264: 436-440.
31. Kamb, A., D. Shattuck-Eidens, R. Eeles, Q. Liu, N.A. Gruis, W. Ding, C. Hussey, T. Tran, Y. Miki, J. Weaver-Feldhaus, M. McClure, J.F. Aitken, D.E. Anderson, W. Bergman, R. Frants, D.E. Goldgar, A. Green, R. MacLennan, N.G. Martin, L.J. Meyer, P. Youl, J.J. Zone, M.H. Skolnick, and L.A. Cannon-Albright. 1994b. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet. 8: 22-26.
32. ARF. Cell 91: 649-659.
33. Kamijo, T., J.D. Weber, G. Zambetti, F. Zindy, M.F. Roussel, and C.J. Sherr. 1998. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl. Acad. Sci. 95: 8292-8297.
34. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R.W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304-6311.
35. Kastan, M.B., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
36. Ko, L.J. and C. Prives. 1996. p53: Puzzle and paradigm. Genes & Dev. 10: 1054-1072.
37. Kubbutat, M.H., S.N. Jones, and K.H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387: 299-303.
38. Kuerbitz, S.J., B.S. Plunkett, W.V. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. 89: 7491-7495.
39. Land, H., L.F. Parada, and R.A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596-602.
40. Lanni, J.S. and T. Jacks. 1998. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18: 1055-1064.
41. Lee, H.-W., M.A. Blasco, G.J. Gottlieb, J.W. Horber, C.W. Greider, and R.A. DePinho. 1998. Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569-574.
42. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
43. Livingstone, L.R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T.D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935.
44. Lloyd, A.C., F. Obermuller, S. Staddon, C.F. Barth, M. McMahon, and H. Land. 1997. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes & Dev. 11: 663-667.
45. Lowe, S.W. and H.E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus-5 E1A and accompanies apoptosis. Genes & Dev. 7: 535-545.
46. Lowe, S.W., H.E. Ruley, T. Jacks, and D.E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-966.
47. INK4a transcript. Cancer Res. 55: 2995-2997.
48. Metz, T., A.W. Harris, and J.M. Adams. 1995. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 82: 29-36.
49. Morgenbesser, S.D., B.O. Williams, T. Jacks, and R.A. DePinho. 1994. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371: 72-74.
50. Pan, H. and A.E. Griep. 1994. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: Implications for tumor suppressor gene function in development. Genes & Dev. 8: 1285-1299.
51. Paulovich, A.C., D.P. Toczyski, and L.H. Hartwell. 1997. When checkpoints fail. Cell 88: 315-321.
52. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92: 713-723.
53. Qin, X.Q., D.M. Livingston, W.G. Kaelin, Jr., and P.D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. 91: 10918-19022.
54. Quelle, D.E., F. Zindy, R.A. Ashmun, and C.J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83: 993-1000.
55. ARF. Proc. Natl. Acad. Sci. 94: 3436-3440.
56. Rao, L., M. Debbas, P. Sabbatini, D. Hockenberry, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis which is inhibited by E1B 19K and Bcl-2 proteins. Proc. Natl. Acad. Sci. 89: 7742-7746.
57. Roth, J., M. Dobbelstein, D. Freedman, T. Shenk, and A.J. Levine. 1998. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17: 554-564.
58. INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta Rev. Cancer (in press).
59. Ruley, H.E. 1983. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304: 602-606.
60. Serrano, M., G.J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.
61. Serrano, M., H.-W. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37.
62. INK4a. Cell 88: 593-602.
63. Shan, B. and W.-H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14: 8166-8173.
64. Sherr, C.J. 1996. Cancer cell cycles. Science 274: 1672-1677.
65. Slebos, R.J.C., M.H. Lee, B.S. Plunkett, T.D. Kessis, B.O. Williams, T. Jacks, L. Hedrick, M.B. Kastan, and K.R. Cho. 1994. p53-dependem G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. 91: 5320-5324.
66. Stone, S., P. Jiang, P. Dayananth, S.V. Tavtigian, H. Katcher, D. Parry, G. Peters, and A. Kamb. 1995. Complex structure and regulation of the p16(MTS1) locus. Cancer Res. 55: 2988-2994.
67. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. (in press).
68. INK4a in primary rat lung tumors. Mol. Cell. Biol. 17: 1366-1374.
69. Symonds, H., L. Krall, L. Remington, M. Saenz-Robles, S. Lowe, T. Jacks, and T. Van Dyke. 1994. p53-dependent apoprosis suppresses tumor growth and progression in vivo. Cell 78: 703-711.
70. Thomas, A. and E. White. 1998. Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function. Genes & Dev. 12: 1975-1985.
71. Van Dyke, T. 1994. Analysis of viral-host protein interactions and tumorigenesis in transgenic mice. Semin. Cancer Biol. 5: 47-60.
72. Wagner, A.J., J.M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 waf1/cip1. Genes & Dev. 8: 2817-2830.
73. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
74. _. 1997. The cat and mouse games that genes, viruses, and cells play. Cell 88: 573-575.
75. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes & Dev. 10: 1-15.
76. White, E., R. Cipriani, P. Sabbatini, and A. Demon. 1991. The adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol 65: 2968-2978.
77. Wu, X. and A.J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. 91: 3602-3606.
78. Wu, X., J.H. Bayle, D. Olson, and A.J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes & Dev. 7: 1126-1132.
79. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
80. Yin, Y., M.A. Tainsky, F.Z. Bischoff, L.C. Strong, and G.M. Wahl 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948.
81. Zhang, Y., Y. Xiong, and W.G. Yarbrough. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways. Cell 92: 725-734.
82. Zindy, F., C.M. Eischen, D. Randle, T. Kamijo, J.L. Cleveland, C.I. Sherr, and M.F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes & Dev. 12: 2424-2434.